Researchers suggest implementation of cardioprotective medications sooner than current guideline recommendations.
Read More »Safety and Efficacy of Lorcaserin
New study focuses on cardiovascular safety of weight loss drug in patients with excess weight or obesity.
Read More »Biomarkers to Predict Cardiovascular Events in People with Type 2 Diabetes
The SUMMIT VIP study shows conventional risk factors do not suffice in predicting heart complications.
Read More »Aspirin No Longer Preventative Drug for Cardiovascular Disease
Increased risk of hemorrhage with no significant lowering of cardiovascular risk means low-dose aspirin recommendations are in peril.
Read More »Omega-3 Supplementation Fails to Prevent Heart Disease
No significant statistical differences found between patients with diabetes using supplement versus placebo.
Read More »Weight After Smoking Cessation Linked with Increased Risk of Type 2 Diabetes
Recent studies show continued benefit in decreasing all-cause mortality from cardiovascular disease.
Read More »Family History of Diabetes and CHD Linked to Poorer Health Outcomes
People with type 2 diabetes found at increased risk for microvascular and macrovascular complications.
Read More »Association Between HbA1c and Coronary Artery Disease
Heart disease said cause of one on every four deaths in the U.S.
Read More »Message For Your Patient: Take Your Medicine
Assessing the costs of not following cholesterol treatment and possible ways to reverse non-adherence
Read More »Young Patients With Type 1 Diabetes Have 4x Higher Risk of Early Death
Patients diagnosed before 10 years of age show increased risk of mortality and cardiovascular disease than those diagnosed at an older age.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.